Retinal Drugs and Biologics Market Report

1. Global Retinal Drugs and Biologics Executive Summary

• 1.1 Introduction

• 1.2 Market Panorama, 2022

2 Coronavirus Impact

• 2.1 Retinal Drugs and Biologics Outlook to 2028- Original Forecasts

• 2.2 Retinal Drugs and Biologics Outlook to 2028- COVID-19 Affected Forecasts

• 2.3 Impact on Industry

3 Strategic Analytics to Boost Productivity and Profitability

• 3.1 Potential Market Drivers and Opportunities

• 3.2 New Challenges and Strategies

• 3.3 Short Term and Long Term Retinal Drugs and Biologics Market Trends

4 Key Inferences

5 Market Overview

• 5.1 Current Market Scenario

• 5.2 Porter's Five Forces Analysis

• 5.2.1 Bargaining Power of Suppliers

• 5.2.2 Bargaining Power of Consumers

• 5.2.3 Threat of New Entrants

• 5.2.4 Threat of Substitute Product and Services

• 5.2.5 Competitive Rivalry within the Industry

6 Global Retinal Drugs and Biologics Market- Recent Developments

• 6.1 Retinal Drugs and Biologics Market News and Developments

• 6.2 Retinal Drugs and Biologics Market Deals Landscape

7 Retinal Drugs and Biologics Raw Materials and Cost Structure Analysis

• 7.1 Retinal Drugs and Biologics Key Raw Materials

• 7.2 Retinal Drugs and Biologics Price Trend of Key Raw Materials

• 7.3 Retinal Drugs and Biologics Key Suppliers of Raw Materials

• 7.4 Retinal Drugs and Biologics Market Concentration Rate of Raw Materials

• 7.5 Retinal Drugs and Biologics Cost Structure Analysis

• 7.5.1 Retinal Drugs and Biologics Raw Materials Analysis

• 7.5.2 Retinal Drugs and Biologics Labor Cost Analysis

• 7.5.3 Retinal Drugs and Biologics Manufacturing Expenses Analysis

8 Global Retinal Drugs and Biologics Import and Export Analysis (Top 10 Countries)

• 8.1 Global Retinal Drugs and Biologics Import by Region (Top 10 Countries) (2017-2028)

• 8.2 Global Retinal Drugs and Biologics Export by Region (Top 10 Countries) (2017-2028)

9 Global Retinal Drugs and Biologics Market Outlook by Types and Applications to 2022

• 9.1 Global Retinal Drugs and Biologics Consumption and Growth Rate by Type (2017-2022)

• 9.1.1 Global Age Related Macular Degeneration Consumption and Growth Rate (2017-2022)

• 9.1.2 Global Diabetic Retinopathy Consumption and Growth Rate (2017-2022)

• 9.1.3 Global Ocular Inflammatory Disease (Uveitis) Consumption and Growth Rate (2017-2022)

• 9.1.4 Global Macular Hole Consumption and Growth Rate (2017-2022)

• 9.2 Global Retinal Drugs and Biologics Consumption and Growth Rate by Application (2017-2022)

• 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

• 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

• 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

10 Region and Country-wise Retinal Drugs and Biologics Market Analysis and Outlook till 2022

• 10.1 Global Retinal Drugs and Biologics Consumption (2017-2022)

• 10.2 North America Consumption Analysis

• 10.2.1 United States Retinal Drugs and Biologics Consumption (2017-2022)

• 10.2.2 Canada Retinal Drugs and Biologics Consumption (2017-2022)

• 10.2.3 Mexico Retinal Drugs and Biologics Consumption (2017-2022)

• 10.3 Europe Consumption Analysis

• 10.3.1 Germany Retinal Drugs and Biologics Consumption (2017-2022)

• 10.3.2 UK Retinal Drugs and Biologics Consumption (2017-2022)

• 10.3.3 Spain Retinal Drugs and Biologics Consumption (2017-2022)

• 10.3.4 Belgium Retinal Drugs and Biologics Consumption (2017-2022)

• 10.3.5 France Retinal Drugs and Biologics Consumption (2017-2022)

• 10.3.6 Italy Retinal Drugs and Biologics Consumption (2017-2022)

• 10.3.7 Denmark Retinal Drugs and Biologics Consumption (2017-2022)

• 10.3.8 Finland Retinal Drugs and Biologics Consumption (2017-2022)

• 10.3.9 Norway Retinal Drugs and Biologics Consumption (2017-2022)

• 10.3.10 Sweden Retinal Drugs and Biologics Consumption (2017-2022)

• 10.3.11 Poland Retinal Drugs and Biologics Consumption (2017-2022)

• 10.3.12 Russia Retinal Drugs and Biologics Consumption (2017-2022)

• 10.3.13 Turkey Retinal Drugs and Biologics Consumption (2017-2022)

• 10.4 APAC Consumption Analysis

• 10.4.1 China Retinal Drugs and Biologics Consumption (2017-2022)

• 10.4.2 Japan Retinal Drugs and Biologics Consumption (2017-2022)

• 10.4.3 India Retinal Drugs and Biologics Consumption (2017-2022)

• 10.4.4 South Korea Retinal Drugs and Biologics Consumption (2017-2022)

• 10.4.5 Pakistan Retinal Drugs and Biologics Consumption (2017-2022)

• 10.4.6 Bangladesh Retinal Drugs and Biologics Consumption (2017-2022)

• 10.4.7 Indonesia Retinal Drugs and Biologics Consumption (2017-2022)

• 10.4.8 Thailand Retinal Drugs and Biologics Consumption (2017-2022)

• 10.4.9 Singapore Retinal Drugs and Biologics Consumption (2017-2022)

• 10.4.10 Malaysia Retinal Drugs and Biologics Consumption (2017-2022)

• 10.4.11 Philippines Retinal Drugs and Biologics Consumption (2017-2022)

• 10.4.12 Vietnam Retinal Drugs and Biologics Consumption (2017-2022)

• 10.5 South America Consumption Analysis

• 10.5.1 Brazil Retinal Drugs and Biologics Consumption (2017-2022)

• 10.5.2 Colombia Retinal Drugs and Biologics Consumption (2017-2022)

• 10.5.3 Chile Retinal Drugs and Biologics Consumption (2017-2022)

• 10.5.4 Argentina Retinal Drugs and Biologics Consumption (2017-2022)

• 10.5.5 Venezuela Retinal Drugs and Biologics Consumption (2017-2022)

• 10.5.6 Peru Retinal Drugs and Biologics Consumption (2017-2022)

• 10.5.7 Puerto Rico Retinal Drugs and Biologics Consumption (2017-2022)

• 10.5.8 Ecuador Retinal Drugs and Biologics Consumption (2017-2022)

• 10.6 GCC Consumption Analysis

• 10.6.1 Bahrain Retinal Drugs and Biologics Consumption (2017-2022)

• 10.6.2 Kuwait Retinal Drugs and Biologics Consumption (2017-2022)

• 10.6.3 Oman Retinal Drugs and Biologics Consumption (2017-2022)

• 10.6.4 Qatar Retinal Drugs and Biologics Consumption (2017-2022)

• 10.6.5 Saudi Arabia Retinal Drugs and Biologics Consumption (2017-2022)

• 10.6.6 United Arab Emirates Retinal Drugs and Biologics Consumption (2017-2022)

• 10.7 Africa Consumption Analysis

• 10.7.1 Nigeria Retinal Drugs and Biologics Consumption (2017-2022)

• 10.7.2 South Africa Retinal Drugs and Biologics Consumption (2017-2022)

• 10.7.3 Egypt Retinal Drugs and Biologics Consumption (2017-2022)

• 10.7.4 Algeria Retinal Drugs and Biologics Consumption (2017-2022)

• 10.8 Oceania Consumption Analysis

• 10.8.1 Australia Retinal Drugs and Biologics Consumption (2017-2022)

• 10.8.2 New Zealand Retinal Drugs and Biologics Consumption (2017-2022)

11 Global Retinal Drugs and Biologics Competitive Analysis

• 11.1 Genentech

• 11.1.1 Genentech Company Details

• 11.1.2 Genentech Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• 11.1.3 Genentech Retinal Drugs and Biologics Main Business and Markets Served

• 11.1.4 Genentech Retinal Drugs and Biologics Product Portfolio

• 11.1.5 Recent Research and Development Strategies

• 11.2 Swedish Orphan Biovitrum

• 11.2.1 Swedish Orphan Biovitrum Company Details

• 11.2.2 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• 11.2.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Main Business and Markets Served

• 11.2.4 Swedish Orphan Biovitrum Retinal Drugs and Biologics Product Portfolio

• 11.2.5 Recent Research and Development Strategies

• 11.3 Bausch & Lomb

• 11.3.1 Bausch & Lomb Company Details

• 11.3.2 Bausch & Lomb Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• 11.3.3 Bausch & Lomb Retinal Drugs and Biologics Main Business and Markets Served

• 11.3.4 Bausch & Lomb Retinal Drugs and Biologics Product Portfolio

• 11.3.5 Recent Research and Development Strategies

• 11.4 UCBCares

• 11.4.1 UCBCares Company Details

• 11.4.2 UCBCares Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• 11.4.3 UCBCares Retinal Drugs and Biologics Main Business and Markets Served

• 11.4.4 UCBCares Retinal Drugs and Biologics Product Portfolio

• 11.4.5 Recent Research and Development Strategies

• 11.5 ALLERGAN

• 11.5.1 ALLERGAN Company Details

• 11.5.2 ALLERGAN Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• 11.5.3 ALLERGAN Retinal Drugs and Biologics Main Business and Markets Served

• 11.5.4 ALLERGAN Retinal Drugs and Biologics Product Portfolio

• 11.5.5 Recent Research and Development Strategies

• 11.6 Roche

• 11.6.1 Roche Company Details

• 11.6.2 Roche Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• 11.6.3 Roche Retinal Drugs and Biologics Main Business and Markets Served

• 11.6.4 Roche Retinal Drugs and Biologics Product Portfolio

• 11.6.5 Recent Research and Development Strategies

• 11.7 Janssen Biotech

• 11.7.1 Janssen Biotech Company Details

• 11.7.2 Janssen Biotech Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• 11.7.3 Janssen Biotech Retinal Drugs and Biologics Main Business and Markets Served

• 11.7.4 Janssen Biotech Retinal Drugs and Biologics Product Portfolio

• 11.7.5 Recent Research and Development Strategies

• 11.8 Genzyme

• 11.8.1 Genzyme Company Details

• 11.8.2 Genzyme Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• 11.8.3 Genzyme Retinal Drugs and Biologics Main Business and Markets Served

• 11.8.4 Genzyme Retinal Drugs and Biologics Product Portfolio

• 11.8.5 Recent Research and Development Strategies

• 11.9 Bristol-Myers Squibb

• 11.9.1 Bristol-Myers Squibb Company Details

• 11.9.2 Bristol-Myers Squibb Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• 11.9.3 Bristol-Myers Squibb Retinal Drugs and Biologics Main Business and Markets Served

• 11.9.4 Bristol-Myers Squibb Retinal Drugs and Biologics Product Portfolio

• 11.9.5 Recent Research and Development Strategies

• 11.10 OCULAR THERAPEUTIX

• 11.10.1 OCULAR THERAPEUTIX Company Details

• 11.10.2 OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• 11.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Main Business and Markets Served

• 11.10.4 OCULAR THERAPEUTIX Retinal Drugs and Biologics Product Portfolio

• 11.10.5 Recent Research and Development Strategies

• 11.11 AbbVie

• 11.11.1 AbbVie Company Details

• 11.11.2 AbbVie Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• 11.11.3 AbbVie Retinal Drugs and Biologics Main Business and Markets Served

• 11.11.4 AbbVie Retinal Drugs and Biologics Product Portfolio

• 11.11.5 Recent Research and Development Strategies

• 11.12 Alimera Sciences

• 11.12.1 Alimera Sciences Company Details

• 11.12.2 Alimera Sciences Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• 11.12.3 Alimera Sciences Retinal Drugs and Biologics Main Business and Markets Served

• 11.12.4 Alimera Sciences Retinal Drugs and Biologics Product Portfolio

• 11.12.5 Recent Research and Development Strategies

12 Global Retinal Drugs and Biologics Market Outlook by Types and Applications to 2028

• 12.1 Global Retinal Drugs and Biologics Consumption Forecast and Growth Rate by Type (2022-2028)

• 12.1.1 Global Age Related Macular Degeneration Consumption Forecast and Growth Rate (2022-2028)

• 12.1.2 Global Diabetic Retinopathy Consumption Forecast and Growth Rate (2022-2028)

• 12.1.3 Global Ocular Inflammatory Disease (Uveitis) Consumption Forecast and Growth Rate (2022-2028)

• 12.1.4 Global Macular Hole Consumption Forecast and Growth Rate (2022-2028)

• 12.2 Global Retinal Drugs and Biologics Consumption Forecast and Growth Rate by Application (2022-2028)

• 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

• 12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

• 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

13 Country-wise Retinal Drugs and Biologics Market Analysis and Outlook to 2028

• 13.1 Global Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.2 North America Consumption Analysis

• 13.2.1 United States Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.2.2 Canada Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.2.3 Mexico Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.3 Europe Consumption Analysis

• 13.3.1 Germany Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.3.2 UK Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.3.3 Spain Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.3.4 Belgium Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.3.5 France Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.3.6 Italy Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.3.7 Denmark Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.3.8 Finland Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.3.9 Norway Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.3.10 Sweden Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.3.11 Poland Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.3.12 Russia Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.3.13 Turkey Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.4 APAC Consumption Analysis

• 13.4.1 China Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.4.2 Japan Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.4.3 India Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.4.4 South Korea Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.4.5 Pakistan Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.4.6 Bangladesh Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.4.7 Indonesia Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.4.8 Thailand Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.4.9 Singapore Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.4.10 Malaysia Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.4.11 Philippines Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.4.12 Vietnam Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.5 South America Consumption Analysis

• 13.5.1 Brazil Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.5.2 Colombia Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.5.3 Chile Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.5.4 Argentina Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.5.5 Venezuela Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.5.6 Peru Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.5.7 Puerto Rico Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.5.8 Ecuador Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.6 GCC Consumption Analysis

• 13.6.1 Bahrain Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.6.2 Kuwait Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.6.3 Oman Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.6.4 Qatar Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.6.5 Saudi Arabia Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.6.6 United Arab Emirates Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.7 Africa Consumption Analysis

• 13.7.1 Nigeria Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.7.2 South Africa Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.7.3 Egypt Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.7.4 Algeria Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.8 Oceania Consumption Analysis

• 13.8.1 Australia Retinal Drugs and Biologics Consumption Forecast (2022-2028)

• 13.8.2 New Zealand Retinal Drugs and Biologics Consumption Forecast (2022-2028)

14 Conclusions

The List of Tables and Figures

• Table Definition of Retinal Drugs and Biologics

• Figure of Retinal Drugs and Biologics Picture

• Table Global Retinal Drugs and Biologics Import by Region (Top 10 Countries) (2017-2028)

• Table Global Retinal Drugs and Biologics Export by Region (Top 10 Countries) (2017-2028)

• Figure Global Age Related Macular Degeneration Consumption and Growth Rate (2017-2022)

• Figure Global Diabetic Retinopathy Consumption and Growth Rate (2017-2022)

• Figure Global Ocular Inflammatory Disease (Uveitis) Consumption and Growth Rate (2017-2022)

• Figure Global Macular Hole Consumption and Growth Rate (2017-2022)

• Figure Global Hospitals Consumption and Growth Rate (2017-2022)

• Figure Global Clinics Consumption and Growth Rate (2017-2022)

• Figure Global Others Consumption and Growth Rate (2017-2022)

• Figure Global Retinal Drugs and Biologics Consumption by Country (2017-2022)

• Table North America Retinal Drugs and Biologics Consumption by Country (2017-2022)

• Figure United States Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Canada Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Mexico Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Table Europe Retinal Drugs and Biologics Consumption by Country (2017-2022)

• Figure Germany Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure UK Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Spain Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Belgium Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure France Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Italy Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Denmark Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Finland Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Norway Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Sweden Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Poland Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Russia Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Turkey Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Table APAC Retinal Drugs and Biologics Consumption by Country (2017-2022)

• Figure China Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Japan Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure India Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure South Korea Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Pakistan Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Bangladesh Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Indonesia Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Thailand Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Singapore Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Malaysia Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Philippines Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Vietnam Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Table South America Retinal Drugs and Biologics Consumption by Country (2017-2022)

• Figure Brazil Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Colombia Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Chile Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Argentina Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Venezuela Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Peru Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Puerto Rico Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Ecuador Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Table GCC Retinal Drugs and Biologics Consumption by Country (2017-2022)

• Figure Bahrain Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Kuwait Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Oman Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Qatar Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Saudi Arabia Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure United Arab Emirates Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Table Africa Retinal Drugs and Biologics Consumption by Country (2017-2022)

• Figure Nigeria Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure South Africa Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Egypt Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure Algeria Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Table Oceania Retinal Drugs and Biologics Consumption by Country (2017-2022)

• Figure Australia Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Figure New Zealand Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)

• Table Genentech Company Details

• Table Genentech Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• Table Genentech Retinal Drugs and Biologics Main Business and Markets Served

• Table Genentech Retinal Drugs and Biologics Product Portfolio

• Table Swedish Orphan Biovitrum Company Details

• Table Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• Table Swedish Orphan Biovitrum Retinal Drugs and Biologics Main Business and Markets Served

• Table Swedish Orphan Biovitrum Retinal Drugs and Biologics Product Portfolio

• Table Bausch & Lomb Company Details

• Table Bausch & Lomb Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• Table Bausch & Lomb Retinal Drugs and Biologics Main Business and Markets Served

• Table Bausch & Lomb Retinal Drugs and Biologics Product Portfolio

• Table UCBCares Company Details

• Table UCBCares Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• Table UCBCares Retinal Drugs and Biologics Main Business and Markets Served

• Table UCBCares Retinal Drugs and Biologics Product Portfolio

• Table ALLERGAN Company Details

• Table ALLERGAN Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• Table ALLERGAN Retinal Drugs and Biologics Main Business and Markets Served

• Table ALLERGAN Retinal Drugs and Biologics Product Portfolio

• Table Roche Company Details

• Table Roche Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• Table Roche Retinal Drugs and Biologics Main Business and Markets Served

• Table Roche Retinal Drugs and Biologics Product Portfolio

• Table Janssen Biotech Company Details

• Table Janssen Biotech Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• Table Janssen Biotech Retinal Drugs and Biologics Main Business and Markets Served

• Table Janssen Biotech Retinal Drugs and Biologics Product Portfolio

• Table Genzyme Company Details

• Table Genzyme Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• Table Genzyme Retinal Drugs and Biologics Main Business and Markets Served

• Table Genzyme Retinal Drugs and Biologics Product Portfolio

• Table Bristol-Myers Squibb Company Details

• Table Bristol-Myers Squibb Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• Table Bristol-Myers Squibb Retinal Drugs and Biologics Main Business and Markets Served

• Table Bristol-Myers Squibb Retinal Drugs and Biologics Product Portfolio

• Table OCULAR THERAPEUTIX Company Details

• Table OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• Table OCULAR THERAPEUTIX Retinal Drugs and Biologics Main Business and Markets Served

• Table OCULAR THERAPEUTIX Retinal Drugs and Biologics Product Portfolio

• Table AbbVie Company Details

• Table AbbVie Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• Table AbbVie Retinal Drugs and Biologics Main Business and Markets Served

• Table AbbVie Retinal Drugs and Biologics Product Portfolio

• Table Alimera Sciences Company Details

• Table Alimera Sciences Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)

• Table Alimera Sciences Retinal Drugs and Biologics Main Business and Markets Served

• Table Alimera Sciences Retinal Drugs and Biologics Product Portfolio

• Figure Global Age Related Macular Degeneration Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Diabetic Retinopathy Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Ocular Inflammatory Disease (Uveitis) Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Macular Hole Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Retinal Drugs and Biologics Consumption Forecast by Country (2022-2028)

• Table North America Retinal Drugs and Biologics Consumption Forecast by Country (2022-2028)

• Figure United States Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Canada Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Mexico Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Table Europe Retinal Drugs and Biologics Consumption Forecast by Country (2022-2028)

• Figure Germany Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure UK Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Spain Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Belgium Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure France Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Italy Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Denmark Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Finland Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Norway Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Sweden Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Poland Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Russia Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Turkey Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Table APAC Retinal Drugs and Biologics Consumption Forecast by Country (2022-2028)

• Figure China Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Japan Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure India Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure South Korea Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Pakistan Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Bangladesh Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Indonesia Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Thailand Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Singapore Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Malaysia Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Philippines Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Vietnam Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Table South America Retinal Drugs and Biologics Consumption Forecast by Country (2022-2028)

• Figure Brazil Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Colombia Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Chile Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Argentina Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Venezuela Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Peru Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Puerto Rico Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Ecuador Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Table GCC Retinal Drugs and Biologics Consumption Forecast by Country (2022-2028)

• Figure Bahrain Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Kuwait Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Oman Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Qatar Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Saudi Arabia Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure United Arab Emirates Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Table Africa Retinal Drugs and Biologics Consumption Forecast by Country (2022-2028)

• Figure Nigeria Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure South Africa Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Egypt Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure Algeria Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Table Oceania Retinal Drugs and Biologics Consumption Forecast by Country (2022-2028)

• Figure Australia Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)

• Figure New Zealand Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)